Advanced or Recurrent Endometrial Cancer Clinical Trial
0 مناظر
• 07/09/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے